Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation.

Xin ChenCharles O ElsonDavid Dunkin

Published in: Inflammatory bowel diseases (2023)

Epicutaneous immunotherapy with MEP1 induced Tregs that migrate to intestines and suppress inflammation in mice with CBir1 or A4Fla2-positive bacterial colonization. This could be a potential strategy to treat CD and warrants further study.

Keyphrases

oxidative stress
diabetic rats
high glucose
mouse model
type diabetes
high fat diet induced
drug induced
human health
stress induced